Recce Ltd has released a press release.
Dose Ranging in Mice - Repeated Success
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- Successful Test Results for Genetic Toxicity
- Anti-viral Activity
- Update on Testing Schedules
- Encouraging Results from Safety Test
- Recce - The Way Forward
Later from Recce Pharmaceuticals
- Pre-clinical toxicology and efficacy testing
- Encouraging anti-viral activity for lead compound RECCE 327
- Lead compound reduces illness in mice infected by E.coli
- Operational Update and Quarterly Cash Flow
- Recce to suspend anti-cancer program
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals